Testing effectiveness (Phase 2)UnknownNCT00003827What this trial is testingCombination Chemotherapy in Treating Patients With Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes ALZA 25
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT01522976What this trial is testingAzacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaWho this might be right forChronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+4 more National Cancer Institute (NCI) 282
Testing effectiveness (Phase 2)Study completedNCT00578942What this trial is testingAllo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using CampathWho this might be right forLymphomaMyelomaLeukemia+2 more David Rizzieri, MD 48
Early research (Phase 1)Study completedNCT01139151What this trial is testing4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesWho this might be right forLeukemia M.D. Anderson Cancer Center 31
Early research (Phase 1)Study completedNCT00891137What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Cellerant Therapeutics 30
Testing effectiveness (Phase 2)Ended earlyNCT01500161What this trial is testingPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more Texas Oncology Cancer Center 1
Very early researchUnknownNCT00434239What this trial is testingLenalidomide and Recombinant Human Stem Cell Factor for Treatment of MyelodysplasiaWho this might be right forMyelodysplasia Peter MacCallum Cancer Centre, Australia 25
Testing effectiveness (Phase 2)Ended earlyNCT00720629What this trial is testingVisilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell TransplantationWho this might be right forGraft Versus Host Disease H. Lee Moffitt Cancer Center and Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT00975975What this trial is testingBasiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood CancerWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+8 more Indiana University 17
Testing effectiveness (Phase 2)Study completedNCT00352001What this trial is testingLenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Mikkael Sekeres MD 37
Not applicableStudy completedNCT04629430What this trial is testingEffects of Prebiotics on Gut Microbiome in Patients Undergoing HSCTWho this might be right forMultiple MyelomaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+9 more University of Virginia 40
Testing effectiveness (Phase 2)Study completedNCT02125877What this trial is testingPhase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)Who this might be right forChronic Iron Overload Due to Transfusion-dependant Anemias Novartis Pharmaceuticals 173
Not applicableStudy completedNCT05260203What this trial is testingMargheRITA (Remote Intelligence for Therapeutic Adherence)Who this might be right forMultiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more Advice Pharma Group srl 124
Testing effectiveness (Phase 2)UnknownNCT02007811What this trial is testingOpen-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single VaccinationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more University of Erlangen-Nürnberg Medical School 15
Large-scale testing (Phase 3)Study completedNCT04060264What this trial is testingClinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal HemoglobinuriaWho this might be right forParoxysmal Nocturnal Hemoglobinuria Biocad 28
Testing effectiveness (Phase 2)Study completedNCT06051357What this trial is testingProof of Concept Study to Assess the Efficacy, Safety of HRS-5965 in Patients With Paroxysmal Nocturnal HemoglobinuriaWho this might be right forParoxysmal Nocturnal Hemoglobinuria Chengdu Suncadia Medicine Co., Ltd. 26
Early research (Phase 1)Study completedNCT04439006What this trial is testingIbrutinib for the Treatment of COVID-19 in Patients Requiring HospitalizationWho this might be right forAplastic AnemiaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+4 more Jennifer Woyach 10
Early research (Phase 1)Study completedNCT06326814What this trial is testingTest if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy AdultsWho this might be right forParoxysmal Nocturnal Hemoglobinuria Sanofi 54
Early research (Phase 1)Ended earlyNCT00234000What this trial is testingAzacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Jonsson Comprehensive Cancer Center 1